Carmel M. Lynch

CDO at ADCendo

Carmel has +25 years of experience in biotechnology, spanning from discovery research to clinical development, with an emphasis in translational medicine. +15 years specializing in ADCs; led Nonclinical and Clinical Pharmacology development of Adcetris(tm) ADC at SeaGen from pre-IND to approval in 2011.

Location

Kenmore, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


ADCendo

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.


Employees

11-50

Links